|
|
| | 1-[[2-(3,6-Diazabicyclo[3.1.1]hept-3-yl)-7-(2-thiazolyl)-4-benzoxazolyl]oxy]-1,1-difluoro-2-methyl-2-propanol Basic information |
| | 1-[[2-(3,6-Diazabicyclo[3.1.1]hept-3-yl)-7-(2-thiazolyl)-4-benzoxazolyl]oxy]-1,1-difluoro-2-methyl-2-propanol Chemical Properties |
| Boiling point | 599.6±60.0 °C(Predicted) | | density | 1.424±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted) | | form | Solid | | pka | 13.38±0.29(Predicted) | | color | White to off-white |
| | 1-[[2-(3,6-Diazabicyclo[3.1.1]hept-3-yl)-7-(2-thiazolyl)-4-benzoxazolyl]oxy]-1,1-difluoro-2-methyl-2-propanol Usage And Synthesis |
| Uses | PDE4-IN-14 (Compound 1) is a PDE4 inhibitor that can be used in the study of PDE4-related diseases (such as inflammatory and immune diseases, cancer, and metabolic diseases, etc.)[1]. | | References | [1] Ko KUMURA, et al. Crystal of benzoxazole derivative. Patent CA3104829A1. |
| | 1-[[2-(3,6-Diazabicyclo[3.1.1]hept-3-yl)-7-(2-thiazolyl)-4-benzoxazolyl]oxy]-1,1-difluoro-2-methyl-2-propanol Preparation Products And Raw materials |
|